LH News Alert Laboratory Corporation of America Holdings (LH)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Laboratory Corporation of America Holdings (LH) 107.69 $LH

SmarTrend Watching for Potential Pullback in Shares of Laboratory Corp of America Holdings After 1.27% Gain
Comtex SmarTrend(R) - Mon Dec 22, 5:27PM CST
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $105.80 to a high of $108.02. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $107.45 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 107.69 (+0.56)

Laboratory Corp of America Holdings Rises 1.27% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Dec 22, 5:26PM CST
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $105.80 to a high of $108.02. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $107.45 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 107.69 (+0.56)

3 Healthcare Technologies That Are Set to Transform Our Lives Over the Next 10-20 Years
Motley Fool Staff - Motley Fool - Sat Dec 20, 5:45PM CST
Source: Touch Bionics. Cutting-edge technology could reshape healthcare over the coming 10-20 years, in the process curbing runaway spending and improving the lives of millions of patients. Which technologies might move the needle most? Three...
DXCM: 54.94 (+0.99), DGX: 67.94 (-0.16), LH: 107.69 (+0.56), WAG: 76.67 (+0.16)

LabCorp Introduces a Test to Identify Enterovirus D-68 (EV-D68)
Business Wire - Thu Dec 18, 7:45AM CST
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today the availability of a reflex test to identify enterovirus D68 (EV-D68), which is associated with severe respiratory illness that primarily affects children.
LH: 107.69 (+0.56)

LabCorp Named Laboratory Service Provider of the Pro Football Legends
PR Newswire - Wed Dec 17, 7:45AM CST
Pro Football Legends, the commercial marketing arm of the National Football League Alumni, Inc. (NFL Alumni) and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) are pleased to announce that they have entered into an agreement for LabCorp to be a sponsor of Pro Football Legends. Under this agreement, LabCorp will offer to provide diagnostic testing services for NFL Alumni members and their families.
LH: 107.69 (+0.56)

2 Large Blood Testing Companies Stand To Be Disrupted
Paulo Santos - at Seeking Alpha - Tue Dec 16, 9:32AM CST

DGX: 67.94 (-0.16), LH: 107.69 (+0.56)

Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance
Business Wire - Tue Dec 16, 7:45AM CST
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) and Covance Inc. (Covance) (NYSE: CVD) jointly announced today the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, in connection with the previously announced merger agreement under which LabCorp will acquire all of the outstanding common stock of Covance. The waiting period expired on Monday, December 15.
LH: 107.69 (+0.56), CVD: 103.73 (+0.02)

United States Medical Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/lncwzs/medical) has announced the addition of Plunkett Research Ltd's new report "Medical Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical Laboratories Industry (U.S.) to reach $218.2 billion by 2021. - Medical Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - Medytox Solutions Inc - NeoGenomics Inc - Psychemedics Corporation - Quest Diagnostics Inc For more information visit http://www.researchandmarkets.com/research/lncwzs/medical Source: Plunkett Research Ltd
PMD: 14.90 (+0.05), HH: 0.53 (unch), BRLI: 31.82 (+0.55), NEO: 4.03 (-0.10), DGX: 67.94 (-0.16), LH: 107.69 (+0.56), GHDX: 32.44 (+1.32)

United States Ambulatory Health Care Services Industry Analytics 2014-2021: Market to reach $1.4 trillion by 2021
M2 - Mon Dec 15, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/kcxkrm/ambulatory_health) has announced the addition of Plunkett Research Ltd's new report "Ambulatory Health Care Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Ambulatory Health Care Services Industry (U.S.) to reach $1.4 trillion by 2021. - Ambulatory Health Care Services Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Apria Healthcare Group Inc - DaVita Healthcare Partners Inc - Fresenius Medical Care North America - HealthSouth Corp - Laboratory Corp of America Holdings - Lincare Holdings Inc - MEDNAX Inc - Magellan Health Inc - Quest Diagnostics Inc - Team Health Holdings Inc For more information visit http://www.researchandmarkets.com/research/kc...ory_health Source: Plunkett Research Ltd
DGX: 67.94 (-0.16), LH: 107.69 (+0.56), HLS: 40.45 (+0.12), MD: 66.81 (+0.17)

United States Medical and Diagnostic Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6lcqc/medical_and) has announced the addition of Plunkett Research Ltd's new report "Medical and Diagnostic Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical and Diagnostic Laboratories Industry (U.S.) to reach $80.8 billion by 2021. - Medical and Diagnostic Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements Companies Mentioned - Alliance Healthcare Services Inc - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - NeoGenomics Inc - Quest Diagnostics Inc - RadNet Inc For more information visit http://www.researchandmarkets.com/research/k6...edical_and Source: Plunkett Research Ltd
HH: 0.53 (unch), BRLI: 31.82 (+0.55), RDNT: 9.41 (-0.08), NEO: 4.03 (-0.10), DGX: 67.94 (-0.16), LH: 107.69 (+0.56), GHDX: 32.44 (+1.32)

COVANCE INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Fri Dec 12, 12:08PM CST
Rigrodsky & Long, P.A.:
LH: 107.69 (+0.56), CVD: 103.73 (+0.02)

Bio-Reference Laboratories Tested: Undisclosed Lawsuit Alleges Fraud, Ex-Employees Speak Out
The GeoTeam - Seeking Alpha - Wed Dec 10, 9:15AM CST
By now, some of the extremely obvious risks to investing in Bio-Reference Laboratories (NASDAQ: BRLI ) have been in the public domain for a while. Questions have been raised about ties to organized crime, stuffing envelopes full of cash for...
BRLI: 31.82 (+0.55), DGX: 67.94 (-0.16), LH: 107.69 (+0.56)

LabCorp Buys DNA Testing Firm, Expands Forensics Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 1:00PM CST
Management at LabCorp (LH) is optimistic that this acquisition will enhance the company's range of forensics and DNA identification testing services.
ABC: 91.60 (+0.18), LH: 107.69 (+0.56), MMSI: 17.17 (+0.01), CVD: 103.73 (+0.02)

Advanced Animal Diagnostics Closes $15 Million in Oversubscribed Series C Funding
PR Newswire - Mon Dec 08, 10:01AM CST
Advanced Animal Diagnostics (AAD) announced today the close of a $15 million Series C round of equity financing. The financing was co-led by Cultivian Sandbox and Kansas Bioscience Authority and included Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), Middleland Capital, and existing investors Intersouth Partners, Novartis Venture Funds and private individuals. The investment will allow AAD to accelerate the commercialization of its current product offering, QScout® MLD (milk leukocyte differential) test, while also expanding the company's product line.
LH: 107.69 (+0.56)

Investor Lawsuit Against Takeover of Covance Inc. (CVD) Announced by Shareholders Foundation
GlobeNewswire - Mon Dec 08, 9:15AM CST
The Shareholders Foundation, Inc. announces that an investor, who currently holds shares of Covance Inc. (CVD), filed a lawsuit in effort to stop the proposed takeover of Covance Inc. by Laboratory Corporation of America Holdings for a value of approximately $105.12 per CVD share.
LH: 107.69 (+0.56), CVD: 103.73 (+0.02)

Health Care Services Equities Technical Commentary - Express Scripts Holding, DaVita HealthCare Partners, Omnicare, Laboratory Corp. of America, and Catamaran
PR Newswire - Mon Dec 08, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Company (NASDAQ:ESRX), DaVita HealthCare Partners Inc. (NYSE: DVA), Omnicare Inc. (NYSE: OCR), Laboratory Corporation of America Holdings (NYSE: LH), and Catamaran Corporation (NASDAQ: CTRX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, December 05, 2014, the NASDAQ Composite ended at 4,780.76, up 0.24%, the Dow Jones Industrial Average advanced 0.33%, to finish the day at 17,958.79, and the S&P 500 closed at 2,075.37, up 0.17%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 817.34, up 0.77%, with the index also advancing 5.43% in the last one month. Register for your complimentary reports on these five stocks at:
CTRX: 51.83 (+0.14), OCR: 73.20 (+0.33), ESRX: 85.48 (-0.40), DVA: 76.06 (+0.07), LH: 107.69 (+0.56)

LabCorp acquires Bode Technology
M2 - Mon Dec 08, 7:24AM CST
Diagnostic technologies company Laboratory Corporation of America Holdings (NYSE:LH) said on Friday that it has acquired Bode Technology Group from SolutionPoint International.
LH: 107.69 (+0.56)

Look for Shares of Laboratory Corp of America Holdings to Potentially Pullback after Yesterday's 1.29% Rise
Comtex SmarTrend(R) - Fri Dec 05, 4:32PM CST
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $104.80 to a high of $107.12. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $106.00 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 107.69 (+0.56)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 76

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 110

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Adcendo’s Early Sarcoma Data Earns a Careful Look

Updated Category News Views 71

Sarcoma data rarely gives anyone permission to pound the table, yet Adcendo’s first look at ADCE-D01 deserves more than a polite nod. In advanced soft tissue sarcoma, where patients have often run through the usual options and second-line response rates historically sit around 4% to 10%, a reported 30% objective response rate on the every-two-week schedule is...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 73

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
Why Professional Collaboration May Matter More in AI

Updated Category News Views 43

Three smart professionals can still hand a client a mess when nobody owns the handoff. That unglamorous reality sits behind the Professional Collaboration Institute, or PCI, which Sarano and Brooke Kelley plan to launch in a virtual briefing on December 2. The outfit wants to turn cross-profession coordination into a teachable, measurable discipline rather than leave it...

Continue Reading
Dental Exams Are Routine Until They Catch Something Early

Updated Category News Views 60

A mouth can look perfectly fine right up until it does not. That is the unglamorous value in the dental exam and X-rays visit described by Dr. Eric Runyon of Smiles Unlimited in Belton, Missouri: it is a structured look for trouble before pain, swelling, or a cracked tooth forces the issue. Nobody throws a parade for preventive care, but waiting for symptoms has a habit...

Continue Reading
Institutions Spread AI Bets as 2027 Risks Mount Higher

Updated Category News Views 89

Money managers are not fleeing the party; they are checking the fire exits. Natixis Investment Managers surveyed 515 institutions overseeing $42.7 trillion, and their 2027 posture is pretty plain: keep taking risk, just stop pretending every risk is the same. Inflation, rates, government debt, geopolitical fracture and an AI spending boom are all tugging at portfolios at...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 148

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
es